Repare Therapeutics Inc. (RPTX)

Latest Insider Confidence Score

2026Q1

50.0
Bearish

Company insider confidence (by quarter)

2020Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Gadicke Ansbert 10% Owner 3,882,485 Jul 13, 2021
Jerel Davis Director 2,325,662 Jan 3, 2023
Redmile Group, LLC — 1,586,174 Jun 25, 2020
Green Jeremy — 1,586,174 Jun 25, 2020
Evnin Luke 10% Owner 952,191 Jun 25, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 28, 2026 Jan 30, 2026 BVF PARTNERS L P/IL 10% Owner Neutral 27.5 -10,166,943 -100.00% ✗ -
Jan 28, 2026 Jan 28, 2026 SCHAFER CAROL Director Neutral 27.5 -8,000 -100.00% ✗ -
Jan 28, 2026 Jan 28, 2026 RHOADS ANN D Director Neutral 27.5 -4,000 -100.00% ✗ -
Jan 28, 2026 Jan 28, 2026 Civik Thomas Director Neutral 27.5 -7,500 -100.00% ✗ -
Jan 28, 2026 Jan 28, 2026 Forte Steve CFO Neutral 27.5 -56,786 -100.00% ✗ -
Jan 28, 2026 Jan 28, 2026 Alves Sandra Isabelle Barros SVP, Finance and CAO Neutral 27.5 -31,622 -100.00% ✗ -
Apr 2, 2025 Apr 29, 2025 Alves Sandra Isabelle Barros SVP, Finance and CAO Neutral 90.0 +4,100 16.06% ✗ -
Apr 29, 2025 Alves Sandra Isabelle Barros SVP, Finance and CAO Neutral 52.5 - 0.00% ✗ -
Apr 2, 2025 Apr 4, 2025 Forte Steve CFO Neutral 52.5 - 0.00% ✗ -
Mar 12, 2025 Mar 14, 2025 Koehler Maria EVP, CHIEF MEDICAL OFFICER Sell 47.5 -3,596 -1.55% ✗ $4.1K
Mar 12, 2025 Mar 14, 2025 Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Sell 47.5 -5,611 -6.53% ✗ $6.4K
Mar 12, 2025 Mar 14, 2025 Forte Steve CFO Sell 47.5 -6,884 -11.16% ✗ $7.8K
Mar 12, 2025 Mar 14, 2025 Segal Lloyd Mitchell CEO Sell 46.3 -21,179 -8.37% ✗ $24.1K
Mar 4, 2025 Mar 6, 2025 Segal Lloyd Mitchell CEO Neutral 90.0 +40,000 18.77% ✗ -
Mar 4, 2025 Mar 6, 2025 Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Neutral 90.0 +14,000 19.47% ✗ -
Mar 4, 2025 Mar 6, 2025 Forte Steve CFO Neutral 90.0 +14,000 29.37% ✗ -
Jun 17, 2024 Jun 20, 2024 SCHAFER CAROL Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 RHOADS ANN D Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 Morrison Briggs Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 Molineaux Susan Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 Kulkarni Samarth Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 Bonita David P Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 20, 2024 Stein Steven H Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Stein Steven H Director Neutral 52.5 - 0.00% ✗ -
Mar 28, 2024 Apr 1, 2024 Segal Lloyd Mitchell CEO Sell 45.0 -5,141 -2.39% ✓ $23.8K
Mar 28, 2024 Apr 1, 2024 Forte Steve CFO Sell 42.5 -1,614 -3.48% ✓ $7.4K
Mar 28, 2024 Apr 1, 2024 Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Sell 50.0 -860 -1.18% ✓ $4K
Mar 28, 2024 Apr 1, 2024 Koehler Maria EVP, CHIEF MEDICAL OFFICER Sell 53.8 -800 -0.34% ✓ $3.7K
Mar 25, 2024 Mar 27, 2024 Forte Steve CFO Sell 36.3 -2,475 -5.54% ✓ $11.6K
Mar 25, 2024 Mar 27, 2024 Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Sell 50.0 -1,350 -1.82% ✓ $6.3K
Mar 25, 2024 Mar 27, 2024 Koehler Maria EVP, CHIEF MEDICAL OFFICER Sell 52.5 -1,500 -0.64% ✓ $7K
Mar 25, 2024 Mar 27, 2024 Segal Lloyd Mitchell CEO Sell 41.3 -7,950 -3.67% ✓ $37.3K
Mar 1, 2024 Mar 5, 2024 Forte Steve CFO Neutral 90.0 +14,000 45.62% ✗ -
Mar 1, 2024 Mar 4, 2024 Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Neutral 90.0 +14,000 23.29% ✗ -
Mar 1, 2024 Mar 4, 2024 Segal Lloyd Mitchell CEO Neutral 90.0 +40,000 22.33% ✗ -
Mar 1, 2024 Mar 4, 2024 Koehler Maria EVP, CHIEF MEDICAL OFFICER Neutral 85.0 +14,000 6.37% ✗ -
Dec 11, 2023 Dec 12, 2023 Koehler Maria EVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 15, 2023 Nov 17, 2023 BVF PARTNERS L P/IL 10% Owner Buy 96.3 +1,227,301 6.52% ✗ $6.2M
Nov 2, 2023 Nov 3, 2023 BVF PARTNERS L P/IL 10% Owner Buy 95.0 +783,709 9.61% ✗ $2.8M
Jun 8, 2023 Jun 12, 2023 SCHAFER CAROL Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 RHOADS ANN D Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Morrison Briggs Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Molineaux Susan Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Kulkarni Samarth Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Foley Todd Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Bonita David P Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Molineaux Susan Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Zinda Michael EVP, Chief Scientific Officer Sell 45.0 -3,535 -2.79% ✓ $42.6K
Jun 6, 2023 Jun 7, 2023 Zinda Michael EVP, Chief Scientific Officer Sell 48.8 -1,200 -1.70% ✓ $14.4K
Jan 30, 2023 Feb 1, 2023 Zinda Michael EVP, Chief Scientific Officer Neutral 90.0 +24,550 53.32% ✗ -
Jan 30, 2023 Feb 1, 2023 Koehler Maria EVP, Chief Medical Officer Neutral 90.0 +26,450 17.69% ✗ -
Jan 30, 2023 Feb 1, 2023 Segal Lloyd Mitchell CEO Neutral 90.0 +78,550 78.09% ✗ -
Jan 30, 2023 Feb 1, 2023 Forte Steve CFO Neutral 90.0 +24,530 398.41% ✗ -
Dec 29, 2022 Jan 3, 2023 Jerel Davis Director Neutral 27.5 -322,956 -27.22% ✗ -
Dec 20, 2022 Dec 20, 2022 Koehler Maria EVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 9, 2022 Dec 13, 2022 Jerel Davis Director Sell 17.5 -250,000 -10.57% ✗ $4M
Jun 13, 2022 Jun 15, 2022 BVF PARTNERS L P/IL 10% Owner Buy 87.5 +149,161 1.86% ✗ $1.9M
Jun 3, 2022 Jun 7, 2022 Versant Vantage I, L.P. 10% Owner Sell 16.3 -1,450,000 -20.47% ✗ $9.2M
Jun 3, 2022 Jun 7, 2022 Versant Ventures V, LLC 10% Owner Sell 16.3 -1,450,000 -22.51% ✗ $9.2M
Jun 3, 2022 Jun 7, 2022 Jerel Davis Director Sell 16.3 -1,440,899 -20.99% ✗ $9.2M
Jun 2, 2022 Jun 6, 2022 BVF PARTNERS L P/IL 10% Owner Buy 97.5 +1,836,958 8.53% ✗ $21.9M
May 18, 2022 May 20, 2022 BVF PARTNERS L P/IL 10% Owner Buy 95.0 +420,000 7.30% ✗ $3.6M
May 13, 2022 May 16, 2022 SCHAFER CAROL Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 RHOADS ANN D Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 Foley Todd Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 Jerel Davis Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 Morrison Briggs Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 Kulkarni Samarth Director Neutral 52.5 - 0.00% ✗ -
May 13, 2022 May 16, 2022 Bonita David P Director Neutral 52.5 - 0.00% ✗ -
Mar 15, 2022 Mar 16, 2022 Zinda Michael EVP, Chief Science Officer Sell 50.0 -533 -1.14% ✓ $6K
Jan 21, 2022 Jan 24, 2022 Segal Lloyd Mitchell CEO Neutral 52.5 - 0.00% ✗ -
Jan 19, 2022 Jan 21, 2022 BVF PARTNERS L P/IL 10% Owner Buy 100.0 +997,961 21.00% ✗ $14.1M
Jan 18, 2022 Jan 20, 2022 Forte Steve CFO Neutral 52.5 - 0.00% ✗ -
Jan 18, 2022 Jan 20, 2022 Koehler Maria EVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 18, 2022 Jan 20, 2022 Zinda Michael EVP, Chief Science Officer Neutral 52.5 - 0.00% ✗ -
Jan 18, 2022 Jan 20, 2022 Segal Lloyd Mitchell CEO Neutral 52.5 - 0.00% ✗ -
Dec 10, 2021 Dec 10, 2021 Koehler Maria EVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 23, 2021 Dec 6, 2021 Zinda Michael EVP, Chief Science Officer Neutral 52.5 - 0.00% ✗ -
Nov 16, 2021 Nov 18, 2021 Civik Thomas Director Buy 95.0 +7,500 100.00% ✗ $210.6K
Nov 15, 2021 Nov 17, 2021 Zinda Michael EVP, Chief Science Officer Sell 7.5 -20,000 -97.40% ✓ $546.6K
Nov 8, 2021 BVF PARTNERS L P/IL 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 7, 2021 Sep 9, 2021 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Sep 3, 2021 Sep 8, 2021 Bonita David P Director Sell 47.5 -8,084 -0.12% ✓ $274.8K
Sep 3, 2021 Sep 8, 2021 ORBIMED ADVISORS LLC Director Sell 47.5 -8,084 -0.12% ✓ $274.8K
Aug 31, 2021 Sep 2, 2021 ORBIMED ADVISORS LLC Director Sell 43.8 -37,864 -0.38% ✓ $1.3M
Aug 31, 2021 Sep 2, 2021 Bonita David P Director Sell 43.8 -37,864 -0.38% ✓ $1.3M
Aug 26, 2021 Aug 30, 2021 ORBIMED ADVISORS LLC Director Sell 47.5 -18,073 -0.18% ✓ $615.7K
Aug 26, 2021 Aug 30, 2021 Bonita David P Director Sell 47.5 -18,073 -0.18% ✓ $615.7K
Aug 23, 2021 Aug 25, 2021 ORBIMED ADVISORS LLC Director Sell 47.5 -18,215 -0.18% ✓ $622.4K
Aug 23, 2021 Aug 25, 2021 Bonita David P Director Sell 47.5 -18,215 -0.18% ✓ $622.4K
Aug 17, 2021 Aug 25, 2021 Bonita David P Director Sell 46.3 -20,328 -0.30% ✓ $693.2K
Aug 16, 2021 Aug 20, 2021 Zinda Michael EVP, Chief Science Officer Sell 7.5 -15,000 -42.21% ✓ $509.9K
Aug 17, 2021 Aug 19, 2021 ORBIMED ADVISORS LLC Director Sell 46.3 -20,328 -0.30% ✓ $693.2K
Aug 17, 2021 Aug 19, 2021 Bonita David P Director Sell 46.3 -20,328 -0.30% ✓ $693.2K
Aug 5, 2021 Aug 9, 2021 Versant Ventures V, LLC 10% Owner Neutral 15.0 -152,071 -39.21% ✓ -
Aug 5, 2021 Aug 9, 2021 Jerel Davis Director Neutral 15.0 -152,052 -38.05% ✓ -